Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intracranial Arteriosclerosis | 21 | 2022 | 50 | 3.370 |
Why?
|
| Stroke | 18 | 2022 | 1225 | 1.360 |
Why?
|
| Magnetic Resonance Angiography | 8 | 2022 | 202 | 0.910 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 8 | 2020 | 25 | 0.870 |
Why?
|
| Ischemic Attack, Transient | 6 | 2021 | 96 | 0.850 |
Why?
|
| Intracranial Arterial Diseases | 4 | 2013 | 7 | 0.580 |
Why?
|
| Cerebrovascular Disorders | 3 | 2015 | 89 | 0.510 |
Why?
|
| Precision Medicine | 2 | 2016 | 134 | 0.510 |
Why?
|
| Collateral Circulation | 1 | 2015 | 28 | 0.450 |
Why?
|
| Hemodynamics | 6 | 2020 | 253 | 0.440 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2021 | 2324 | 0.430 |
Why?
|
| Clinical Trials as Topic | 2 | 2015 | 462 | 0.420 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2014 | 190 | 0.390 |
Why?
|
| Cerebral Angiography | 8 | 2014 | 303 | 0.390 |
Why?
|
| Data Collection | 1 | 2014 | 384 | 0.370 |
Why?
|
| Cerebrovascular Circulation | 4 | 2020 | 228 | 0.360 |
Why?
|
| Brain Infarction | 2 | 2021 | 21 | 0.330 |
Why?
|
| Brain Ischemia | 2 | 2014 | 423 | 0.320 |
Why?
|
| Constriction, Pathologic | 8 | 2021 | 131 | 0.320 |
Why?
|
| Risk | 1 | 2010 | 375 | 0.300 |
Why?
|
| Diagnostic Imaging | 2 | 2015 | 274 | 0.290 |
Why?
|
| Middle Cerebral Artery | 3 | 2021 | 53 | 0.280 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2022 | 1665 | 0.280 |
Why?
|
| Cerebral Arteries | 1 | 2007 | 45 | 0.250 |
Why?
|
| Humans | 40 | 2022 | 65837 | 0.230 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2018 | 126 | 0.230 |
Why?
|
| Hydrodynamics | 2 | 2015 | 43 | 0.220 |
Why?
|
| Middle Aged | 21 | 2021 | 18498 | 0.210 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2021 | 34 | 0.210 |
Why?
|
| Recurrence | 6 | 2021 | 665 | 0.200 |
Why?
|
| Stroke Rehabilitation | 2 | 2015 | 51 | 0.200 |
Why?
|
| Prognosis | 5 | 2020 | 1794 | 0.200 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2021 | 172 | 0.200 |
Why?
|
| Aged | 19 | 2021 | 15146 | 0.190 |
Why?
|
| Computer Simulation | 2 | 2015 | 488 | 0.180 |
Why?
|
| Thromboembolism | 2 | 2021 | 74 | 0.180 |
Why?
|
| Cerebral Infarction | 2 | 2021 | 88 | 0.170 |
Why?
|
| Male | 23 | 2021 | 31406 | 0.170 |
Why?
|
| Predictive Value of Tests | 5 | 2021 | 1117 | 0.170 |
Why?
|
| Perfusion Imaging | 1 | 2021 | 25 | 0.170 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2021 | 99 | 0.160 |
Why?
|
| Risk Factors | 9 | 2021 | 5476 | 0.160 |
Why?
|
| Risk Assessment | 5 | 2020 | 2115 | 0.160 |
Why?
|
| Intracranial Embolism | 1 | 2020 | 41 | 0.160 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2020 | 20 | 0.160 |
Why?
|
| Female | 22 | 2021 | 34423 | 0.150 |
Why?
|
| Snoring | 1 | 2018 | 8 | 0.140 |
Why?
|
| Lipids | 1 | 2021 | 331 | 0.140 |
Why?
|
| Respiratory System | 1 | 2018 | 46 | 0.140 |
Why?
|
| Blood Flow Velocity | 2 | 2019 | 79 | 0.140 |
Why?
|
| Reproducibility of Results | 4 | 2018 | 1719 | 0.140 |
Why?
|
| Thrombolytic Therapy | 2 | 2018 | 205 | 0.140 |
Why?
|
| Epidural Abscess | 1 | 2017 | 9 | 0.130 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2018 | 61 | 0.130 |
Why?
|
| Cone-Beam Computed Tomography | 2 | 2017 | 73 | 0.130 |
Why?
|
| Early Diagnosis | 1 | 2017 | 95 | 0.130 |
Why?
|
| Spinal Diseases | 1 | 2017 | 50 | 0.130 |
Why?
|
| Length of Stay | 1 | 2021 | 828 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 312 | 0.130 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 170 | 0.130 |
Why?
|
| Research Design | 1 | 2020 | 589 | 0.130 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2017 | 27 | 0.120 |
Why?
|
| Clinical Protocols | 1 | 2017 | 138 | 0.120 |
Why?
|
| United States | 5 | 2020 | 8189 | 0.120 |
Why?
|
| Hematocrit | 1 | 2015 | 32 | 0.120 |
Why?
|
| Cognition | 1 | 2020 | 514 | 0.120 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 242 | 0.110 |
Why?
|
| Prospective Studies | 5 | 2021 | 3339 | 0.110 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 360 | 0.110 |
Why?
|
| Manipulation, Spinal | 1 | 2014 | 3 | 0.110 |
Why?
|
| Time Factors | 5 | 2020 | 3777 | 0.110 |
Why?
|
| Vertebral Artery Dissection | 1 | 2014 | 22 | 0.100 |
Why?
|
| Common Data Elements | 1 | 2014 | 5 | 0.100 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 5682 | 0.100 |
Why?
|
| Basilar Artery | 1 | 2013 | 34 | 0.100 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 1172 | 0.100 |
Why?
|
| Telephone | 1 | 2014 | 123 | 0.100 |
Why?
|
| Carotid Artery, Internal | 1 | 2013 | 69 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2015 | 537 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2017 | 473 | 0.090 |
Why?
|
| Physicians | 1 | 2018 | 488 | 0.090 |
Why?
|
| Software | 1 | 2015 | 401 | 0.090 |
Why?
|
| Angiography, Digital Subtraction | 3 | 2019 | 140 | 0.090 |
Why?
|
| Carotid Stenosis | 1 | 2013 | 100 | 0.090 |
Why?
|
| Retrospective Studies | 6 | 2021 | 6955 | 0.080 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1990 | 67 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 2790 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 489 | 0.080 |
Why?
|
| Stents | 2 | 2013 | 501 | 0.080 |
Why?
|
| Angioplasty, Balloon | 1 | 2009 | 56 | 0.070 |
Why?
|
| Anticoagulants | 2 | 2011 | 529 | 0.070 |
Why?
|
| Aging | 1 | 2014 | 784 | 0.070 |
Why?
|
| Computed Tomography Angiography | 2 | 2022 | 143 | 0.070 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2009 | 235 | 0.070 |
Why?
|
| Adult | 9 | 2021 | 17575 | 0.060 |
Why?
|
| Brain | 2 | 2013 | 1672 | 0.050 |
Why?
|
| Pilot Projects | 3 | 2015 | 1029 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1569 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 809 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2021 | 71 | 0.040 |
Why?
|
| China | 2 | 2013 | 181 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2021 | 104 | 0.040 |
Why?
|
| Rupture, Spontaneous | 1 | 2020 | 22 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2018 | 5834 | 0.040 |
Why?
|
| Cholesterol | 1 | 2021 | 262 | 0.040 |
Why?
|
| Neurology | 2 | 2015 | 44 | 0.040 |
Why?
|
| Triglycerides | 1 | 2021 | 249 | 0.040 |
Why?
|
| Arousal | 1 | 2018 | 42 | 0.040 |
Why?
|
| Polysomnography | 1 | 2018 | 61 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2018 | 78 | 0.030 |
Why?
|
| Decision Making, Organizational | 1 | 2017 | 25 | 0.030 |
Why?
|
| Efficiency, Organizational | 1 | 2017 | 98 | 0.030 |
Why?
|
| Biomarkers | 1 | 2021 | 1502 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 2500 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 464 | 0.030 |
Why?
|
| Incidence | 2 | 2008 | 1433 | 0.030 |
Why?
|
| Contrast Media | 1 | 2017 | 435 | 0.030 |
Why?
|
| Prevalence | 2 | 2008 | 1453 | 0.030 |
Why?
|
| Probability | 1 | 2015 | 170 | 0.030 |
Why?
|
| Algorithms | 1 | 2019 | 1060 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 498 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 136 | 0.020 |
Why?
|
| Social Behavior | 1 | 2014 | 85 | 0.020 |
Why?
|
| Health Resources | 1 | 2014 | 92 | 0.020 |
Why?
|
| Asymptomatic Diseases | 1 | 2013 | 52 | 0.020 |
Why?
|
| Observer Variation | 1 | 2013 | 217 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2014 | 197 | 0.020 |
Why?
|
| Endarterectomy, Carotid | 1 | 2013 | 79 | 0.020 |
Why?
|
| Survivors | 1 | 2014 | 187 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2014 | 757 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2014 | 293 | 0.020 |
Why?
|
| Radiography | 1 | 2013 | 559 | 0.020 |
Why?
|
| Family | 1 | 2014 | 250 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2015 | 264 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 806 | 0.020 |
Why?
|
| Decision Making | 1 | 2015 | 430 | 0.020 |
Why?
|
| Social Support | 1 | 2014 | 394 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2014 | 398 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 1122 | 0.020 |
Why?
|
| Caregivers | 1 | 2014 | 298 | 0.020 |
Why?
|
| Warfarin | 1 | 2011 | 125 | 0.020 |
Why?
|
| Aspirin | 1 | 2011 | 172 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 715 | 0.020 |
Why?
|
| Hallucinations | 1 | 1989 | 17 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2011 | 183 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 711 | 0.020 |
Why?
|
| Models, Biological | 1 | 2014 | 1193 | 0.020 |
Why?
|
| Epilepsy | 1 | 1989 | 113 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 1991 | 995 | 0.020 |
Why?
|
| Quality of Life | 1 | 2014 | 1267 | 0.020 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2004 | 13 | 0.010 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2004 | 10 | 0.010 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 65 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 4882 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2004 | 170 | 0.010 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2004 | 110 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 2004 | 292 | 0.010 |
Why?
|
| Echocardiography | 1 | 2004 | 513 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2004 | 2089 | 0.010 |
Why?
|
| Child | 1 | 2004 | 4651 | 0.010 |
Why?
|
| Animals | 1 | 2012 | 21493 | 0.010 |
Why?
|
| Adolescent | 1 | 2004 | 6367 | 0.010 |
Why?
|
| Dissociative Disorders | 1 | 1989 | 8 | 0.000 |
Why?
|